These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 9092286)

  • 21. Therapy of invasive bladder cancer.
    Dinney CP
    Urology; 2006 Mar; 67(3 Suppl 1):56-9; discussion 60-1. PubMed ID: 16530078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimal management of the T1G3 bladder cancer.
    Manoharan M; Soloway MS
    Urol Clin North Am; 2005 May; 32(2):133-45. PubMed ID: 15862611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overview of bladder cancer trials in the Radiation Therapy Oncology Group.
    Shipley WU; Kaufman DS; Tester WJ; Pilepich MV; Sandler HM;
    Cancer; 2003 Apr; 97(8 Suppl):2115-9. PubMed ID: 12673704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conservative surgery, patient selection, and chemoradiation as organ-preserving treatment for muscle-invading bladder cancer.
    Douglas RM; Kaufman DS; Zietman AL; Althausen AF; Heney NM; Shipley WU
    Semin Oncol; 1996 Oct; 23(5):614-20. PubMed ID: 8893872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conservative treatment of invasive bladder carcinoma by transurethral resection, protracted intravenous infusion chemotherapy, and hyperfractionated radiotherapy: long term results.
    Danesi DT; Arcangeli G; Cruciani E; Altavista P; Mecozzi A; Saracino B; Orefici F
    Cancer; 2004 Dec; 101(11):2540-8. PubMed ID: 15481058
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase I-II RTOG study (99-06) of patients with muscle-invasive bladder cancer undergoing transurethral surgery, paclitaxel, cisplatin, and twice-daily radiotherapy followed by selective bladder preservation or radical cystectomy and adjuvant chemotherapy.
    Kaufman DS; Winter KA; Shipley WU; Heney NM; Wallace HJ; Toonkel LM; Zietman AL; Tanguay S; Sandler HM
    Urology; 2009 Apr; 73(4):833-7. PubMed ID: 19100600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bladder conservation treatment in the elderly population: results and prognostic factors of muscle-invasive bladder cancer.
    Tran E; Souhami L; Tanguay S; Rajan R
    Am J Clin Oncol; 2009 Aug; 32(4):333-7. PubMed ID: 19381080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Chemoradiotherapy for muscle-invasive cancer: methods, surveillance and results. An update from the cancer committee of the French National Association of Urology].
    Quintens H; Roupret M; Larré S; Neuzillet Y; Pignot G; Compérat E; Wallerand H; Houédé N; Roy C; Soulié M; Pfister C;
    Prog Urol; 2012 Jan; 22(1):13-6. PubMed ID: 22196000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemotherapy for muscle-invasive bladder cancer treated with definitive radiotherapy: persisting uncertainties.
    Choueiri TK; Raghavan D
    Nat Clin Pract Oncol; 2008 Aug; 5(8):444-54. PubMed ID: 18577983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Total cystectomy versus bladder preservation therapy for locally invasive bladder cancer: effect of combined therapy using balloon-occluded arterial infusion of anticancer agent and hemodialysis with concurrent radiation.
    Azuma H; Yamamoto K; Inamoto T; Ibuki N; Kotake Y; Sakamoto T; Kiyama S; Ubai T; Takahara K; Segawa N; Narumi Y; Katsuoka Y
    Am J Clin Oncol; 2009 Dec; 32(6):592-606. PubMed ID: 19593084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Muscle-invasive urothelial carcinoma of the bladder: neoadjuvant chemotherapy enables organ-preserving therapy in carefully selected patients.
    Heidenreich A
    Eur Urol; 2008 Jul; 54(1):21-3. PubMed ID: 18262722
    [No Abstract]   [Full Text] [Related]  

  • 32. A phase I/II trial of transurethral surgery combined with concurrent cisplatin, 5-fluorouracil and twice daily radiation followed by selective bladder preservation in operable patients with muscle invading bladder cancer.
    Zietman AL; Shipley WU; Kaufman DS; Zehr EM; Heney NM; Althausen AF; McGovern FJ
    J Urol; 1998 Nov; 160(5):1673-7. PubMed ID: 9783929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Small cell carcinoma of the urinary bladder. The Mayo Clinic experience.
    Choong NW; Quevedo JF; Kaur JS
    Cancer; 2005 Mar; 103(6):1172-8. PubMed ID: 15700264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [New developments in the treatment of muscle-invasive bladder cancer].
    Kerst JM; Pos FJ; Visser O; Horenblas S
    Ned Tijdschr Geneeskd; 2008 Jan; 152(4):187-92. PubMed ID: 18320942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of chemotherapy and radiation in organ-preservation strategies for muscle-invasive bladder cancer.
    Bradley BA; Wajsman Z
    World J Urol; 2002 Aug; 20(3):167-74. PubMed ID: 12196900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The results of concurrent chemo-radiotherapy for recurrence after treatment with bacillus Calmette-Guérin for non-muscle-invasive bladder cancer: is immediate cystectomy always necessary?
    Wo JY; Shipley WU; Dahl DM; Coen JJ; Heney NM; Kaufman DS; Zietman AL
    BJU Int; 2009 Jul; 104(2):179-83. PubMed ID: 19154448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The management of locally recurrent invasive bladder cancer following radical cystectomy.
    Pisters LL; Westney L
    Semin Urol Oncol; 1996 May; 14(2):112-9. PubMed ID: 8734739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Can patient selection for bladder preservation be based on response to chemotherapy?
    Sternberg CN; Pansadoro V; Calabrò F; Schnetzer S; Giannarelli D; Emiliozzi P; De Paula F; Scarpone P; De Carli P; Pizzo M; Platania A; Amini M
    Cancer; 2003 Apr; 97(7):1644-52. PubMed ID: 12655521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined modality treatment with selective bladder conservation for invasive bladder cancer: long-term tolerance in the female patient.
    Kachnic LA; Shipley WU; Griffin PP; Zietman AL; Kaufman DS; Althausen AF; Heney NM
    Cancer J Sci Am; 1996; 2(2):79-84. PubMed ID: 9166504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Organ conservation in invasive bladder cancer by transurethral resection, chemotherapy and radiation: results of a urodynamic and quality of life study on long-term survivors.
    Zietman AL; Sacco D; Skowronski U; Gomery P; Kaufman DS; Clark JA; Talcott JA; Shipley WU
    J Urol; 2003 Nov; 170(5):1772-6. PubMed ID: 14532773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.